Literature DB >> 31500489

Disseminated peritoneal leiomyomatosis following laparoscopic myomectomy: a case report.

Jianchun Xiao, Ruopeng Zhang1,2, Yue Teng1,2, Beizhan Liu1.   

Abstract

Entities:  

Keywords:  Disseminated peritoneal leiomyomatosis; benign tumors; laparoscopy; preoperative diagnosis; smooth muscle; uterine myomectomy

Mesh:

Year:  2019        PMID: 31500489      PMCID: PMC6997780          DOI: 10.1177/0300060519859137

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


× No keyword cloud information.

Introduction

Disseminated peritoneal leiomyomatosis (DPL) is a rare benign disease characterized by tumors derived from smooth muscles occurring in the abdominal cavity. This condition is thought to be associated with an elevated estrogen level, such as that caused by pregnancy, estrogen replacement therapy, oral contraceptives, and ovarian endocrine tumors.[1] DPL frequently occurs in women of reproductive age, and its growth patterns can resemble those of malignant tumors with active growth. Thus, DPL is easily misdiagnosed prior to surgery. A definitive diagnosis depends on the operative, histopathologic, and immunohistochemical findings. We herein describe a 45-year-old woman with DPL following laparoscopic uterine myomectomy. This case report provides us with a new perspective on the identification of abdominal swelling and reminds us that it is important to pay attention to the patient’s history, especially the surgical history.

Case report

A 45-year-old woman who had undergone laparoscopic uterine myomectomy 10 years previously was found to have abdominal masses on imaging during a routine medical checkup. Pathological examination at that time confirmed a diagnosis of uterine fibroids accompanied by red changes and slight bleeding. She had no history of hormonal therapy or contraception. During the medical checkup 10 years after the myomectomy, a computed tomography (CT) scan revealed a 4.3- × 5.1-cm mass in the ascending colon that was suspected to be a malignant or stromal tumor. A second 2.5- × 3.3-cm mass between the liver and right kidney was assumed to be metastatic spread (Figure 1). Both of the masses were intraperitoneal. However, enteroscopy revealed no abnormalities. The patient underwent a positron emission tomography/CT scan to rule out the possibility of a gastrointestinal stromal tumor (GIST). The maximum standardized uptake value (SUVmax) of the two masses were 2.6 and 1.6 Bq/mL, respectively. The SUVmax of GISTs usually ranges from 2.0 to 2.5 Bq/mL, and a malignant tumor is highly likely when the SUVmax is >2.5 Bq/mL.
Figure 1.

Computed tomography scan revealing the two masses. The left figure shows the extramural colonic mass, and the right figure shows the mass between the liver and right kidney.

Computed tomography scan revealing the two masses. The left figure shows the extramural colonic mass, and the right figure shows the mass between the liver and right kidney. Considering the rapid growth rate and uncertainty of the malignant potential of the masses, the patient underwent laparotomy and mass resection. During the surgery, we found that the larger mass was located outside of the colon lumen, originated from the peritoneum, and adhered to the surface of the ascending colon (Figure 2); this was in contrast to the CT findings, which indicated that the tumor was located in the lumen of the ascending colon. The smaller mass was located in the retroperitoneal space. The excised specimens are shown in Figure 3. The final histopathological examination confirmed a diagnosis of leiomyoma (Figure 4) (CD34 and CD117 negativity, which are inconsistent with the characteristics of GISTs, and smooth muscle actin and desmin positivity, which are consistent with smooth muscle tumors).
Figure 2.

Intraoperative findings. The larger mass was located outside of the colon lumen, adhering to the surface of the ascending colon. The smaller mass was located in the retroperitoneal space.

Figure 3.

The histological appearance of both masses was compatible with the characteristics of a leiomyoma (hematoxylin and eosin staining). Immunohistochemistry revealed negativity for CD34, CD117, DOG-1, S-100, and succinate dehydrogenase subunit B; positivity for smooth muscle actin and desmin; and a Ki-67 index of 5%.

Figure 4.

Excised mass specimens. The specimens were soft, yellow masses with a uniform texture.

Intraoperative findings. The larger mass was located outside of the colon lumen, adhering to the surface of the ascending colon. The smaller mass was located in the retroperitoneal space. The histological appearance of both masses was compatible with the characteristics of a leiomyoma (hematoxylin and eosin staining). Immunohistochemistry revealed negativity for CD34, CD117, DOG-1, S-100, and succinate dehydrogenase subunit B; positivity for smooth muscle actin and desmin; and a Ki-67 index of 5%. Excised mass specimens. The specimens were soft, yellow masses with a uniform texture.

Discussion

The etiology of DPL is unclear. DPL was first reported in 1952 by Willson and Peale,[2] and only about 100 cases have since been reported. Most researchers believe that DPL is related to increases in the estrogen level in the body.[3] In recent years, however, accumulating evidence suggests that iatrogenic factors are important causes of DPL. Few reports have described DPL after myomectomy or hysterectomy; however, DPL has been reported following myomectomy or hysterectomy using laparoscopic surgery.[4] Residual myoma fragments produced during surgery may implant into normal tissue and continue to grow by forming new blood vessels between normal tissues.[5,6] Patients with DPL have normal tumor markers and no specific imaging findings, nor do they have special clinical manifestations or signs. Approximately 50% of patients are asymptomatic, while the remaining patients develop pelvic pain, pelvic cavity discomfort, pelvic and abdominal compression symptoms, and even intestinal obstruction.[7] This lack of specific characteristics results in a very high rate of preoperative misdiagnosis. The definitive diagnosis depends on intraoperative examination findings and pathological results. Several differences exist between DPL and other gastrointestinal tumors such as GISTs. The main pathological manifestation of DPL is dense arrangement of smooth muscle cells and fibroblasts. Immunohistochemical examination often reveals smooth muscle actin and desmin positivity. GISTs generally consist of spindle cells and epithelial-like cells with CD117 CD34 positivity, and most of the spindle cells have unclear boundaries. Pathological examination can generally determine the tumor type. In the present case, CT revealed that one of the masses was located in the ascending colon in close proximity to the adjacent intestinal wall, with its outer part close to the peritoneum. Considering its rapid growth rate, it was suspected to be a malignant tumor. We also considered that this mass could be a GIST, which is the most common mesenchymal tumor in the gastrointestinal tract and can occur in any part of the gastrointestinal tract.[8] GISTs also lack specific clinical manifestations and usually present as round masses with a smooth rim on CT images. The smaller mass between the liver and right kidney was assumed to be metastatic spread. During the intraoperative exploration of the relationship between the larger mass and the peripheral tissue, we found that the mass had not grown on the wall of the intestine but had instead originated from the peritoneum. The intestinal wall was squeezed inward with the tumor growth, explaining why it was closely related to the intestinal wall on the CT image. Histopathological examination revealed that both of the masses were leiomyomas. Considering the patient’s history of laparoscopic uterine myomectomy, we believe that these two masses were DPL possibly caused by the spread of tumor cells by uterine myomectomy. In most other cases, patients have been diagnosed with DPL no more than 10 years after uterine myomectomy. In the present case, however, the patient had undergone uterine myomectomy 10 years previously. This case suggests that even many years after surgery, regular medical examinations are required to detect the occurrence of DPL.

Conclusion

DPL is a very rare disease that can develop after myomectomy. DPL should be considered as a differential diagnosis of intra-abdominal masses in patients with a history of myomectomy. Care should be taken during laparoscopic extraction of myomas.

Abbreviations

DPL: disseminated peritoneal leiomyomatosis, GIST: gastrointestinal stromal tumor; CT: computed tomography; SUVmax: maximum standardized uptake value
  8 in total

1.  Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma.

Authors:  Zehra Ordulu; Paola Dal Cin; Wilson W S Chong; Kwong Wai Choy; Charles Lee; Michael G Muto; Bradley J Quade; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

2.  Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.

Authors:  John A Harris; Carolyn W Swenson; Shitanshu Uppal; Neil Kamdar; Nichole Mahnert; Sawsan As-Sanie; Daniel M Morgan
Journal:  Am J Obstet Gynecol       Date:  2015-08-24       Impact factor: 8.661

3.  Multiple peritoneal leiomyomas associated with a granulosa-cell tumor of the ovary.

Authors:  J R WILLSON; A R PEALE
Journal:  Am J Obstet Gynecol       Date:  1952-07       Impact factor: 8.661

Review 4.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

5.  Leiomyomatosis peritonealis disseminata: an additional case.

Authors:  A Barone; M R Ambrosio; B J Rocca; M G Mastrogiulio; A Ambrosio; R Santopietro
Journal:  Eur J Gynaecol Oncol       Date:  2014       Impact factor: 0.196

6.  Recurrent leiomyomatosis peritonealis disseminata after hysterectomy and bilateral salpingo-oophorectomy during combined hormone replacement therapy.

Authors:  Joerg Heinig; Albert Neff; Ulrich Cirkel; Walter Klockenbusch
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-12-10       Impact factor: 2.435

7.  Leiomyomatosis peritonealis disseminata: pregnancy, contraception and myomectomy of its pathogenesis.

Authors:  M Onorati; G Petracco; P Uboldi; S Romagnoli; M M Amidani; G Bulfamante; F Di Nuovo
Journal:  Pathologica       Date:  2013-06

8.  Leiomyomatosis peritonealis disseminata associated with endometriosis: A case report and review of the literature.

Authors:  Rulin Yang; Tianmin Xu; Yingwei Fu; Songhua Cui; Shuli Yang; Manhua Cui
Journal:  Oncol Lett       Date:  2014-11-27       Impact factor: 2.967

  8 in total
  2 in total

1.  Diffuse Micro-Nodules on Peritoneal Surfaces at Donor Organ Procurement: Highlights on the Diagnostic Challenge and Transplant Management.

Authors:  Albino Eccher; Amedeo Carraro; Ilaria Girolami; Manuela Villanova; Alex Borin; Paola Violi; Barbara Paro; Claudia Mescoli; Deborah Malvi; Luca Novelli; Antonietta D'Errico; Giuseppe Rossini; Marco Ungari
Journal:  Am J Case Rep       Date:  2021-02-13

2.  Treatment of leiomyomatosis peritonealis disseminata with goserelin acetate: A case report and review of the literature.

Authors:  Jia-Wen Yang; Yu Hua; Hua Xu; Liu He; Hai-Zhong Huo; Chen-Fang Zhu
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.